The Falsified Medicines Directive (2011/62/EU) aims to prevent falsified medicines entering the supply chain and reaching patients. The 13th Joint Symposium, organised by the Royal Pharmaceutical Society, the Society of Biology and the ÂÜÀòÉç, will identify changes required by the Directive that are relevant to the Qualified Person.